Oramed Pharmaceuticals Incorporated ORMP
NASDAQ · United States · Health Technology
$4.42-0.07 (-1.45%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-10 | 2.76 | 0.43 | +541.9% | $0 | — | -1.2%$4.30→$4.25 |
| Q1 2026 | 2026-05-19 | -0.16 | — | — | — | — | -0.2%$4.29→$4.28 |
| Q4 2025 | 2026-03-26 | 0.25 | 0.00 | — | — | — | -5.4%$3.50→$3.31 |
| Q3 2025 | 2025-11-13 | 0.00 | -0.04 | +100.0% | — | — | -5.7%$2.47→$2.33 |
| Q4 2024 | 2025-03-27 | -0.26 | -0.02 | -1,200.0% | — | — | — |
| Q4 2023 | 2024-03-06 | 0.33 | -0.01 | +3,400.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.